Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects? Kourid MI, Couillard S. Eur Respir J 2025;65:2500153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kourid MI, Couillard S. Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects? Eur Respir J 2025;65:2500153.
PMID: 40274300